Refine
Year of publication
Document Type
- Conference Proceeding (202) (remove)
Language
- English (108)
- German (86)
- French (5)
- Multiple languages (3)
Keywords
- Psychologie (17)
- Kongress (9)
- Schwertkärpfling (7)
- Immunbiologie (5)
- PET (5)
- Archäologie (4)
- Tagung (4)
- Toxikologie (4)
- Virtuelle Realität (4)
- Vor- und Frühgeschichte (4)
Institute
- Institut für Psychologie (bis Sept. 2007) (47)
- Theodor-Boveri-Institut für Biowissenschaften (26)
- Institut für Mineralogie und Kristallstrukturlehre (12)
- Institut für Psychologie (12)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (12)
- Neuphilologisches Institut - Moderne Fremdsprachen (bis 2007) (12)
- Institut für Informatik (11)
- Institut für deutsche Philologie (11)
- Klinik und Poliklinik für Nuklearmedizin (9)
- Institut für Pharmakologie und Toxikologie (6)
- Institut für Altertumswissenschaften (5)
- Institut Mensch - Computer - Medien (4)
- Institut für Biblische Theologie (4)
- Physikalisches Institut (4)
- Institut für Anatomie und Zellbiologie (3)
- Institut für Archäologie (3)
- Institut für Politische Wissenschaft (3)
- Institut für Pädagogik (3)
- Institut für Virologie und Immunbiologie (3)
- Medizinische Klinik und Poliklinik I (3)
- Institut für Geschichte (2)
- Institut für Mathematik (2)
- Institut für Molekulare Infektionsbiologie (2)
- Martin-von-Wagner-Museum (2)
- Universität Würzburg (2)
- Institut für Anglistik und Amerikanistik (1)
- Institut für Anorganische Chemie (1)
- Institut für Geographie (1)
- Institut für Kulturwissenschaften Ost- und Südasiens (1)
- Institut für Kunstgeschichte (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
- Institut für Politikwissenschaft und Soziologie (1)
- Juristische Fakultät (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
- Neuphilologisches Institut - Moderne Fremdsprachen (1)
- Universitätsbibliothek (1)
Schriftenreihe
Sonstige beteiligte Institutionen
- Johns Hopkins School of Medicine (4)
- Johns Hopkins School of Medicine, Baltimore, MD, U.S. (4)
- Cologne Game Lab (3)
- Open University of the Netherlands (2)
- Badisches Landesmuseum Karlsruhe (1)
- Bayerische Museumsakademie (1)
- Bezirk Unterfranken (1)
- Birmingham City University (1)
- Brown University (1)
- DATE Lab, KITE Research Insititute, University Health Network, Toronto, Canada (1)
EU-Project number / Contract (GA) number
- 701983 (9)
Introduction: The prognosis of medullary thyroid carcinoma (MTC) is poor using common chemotherapeutic approaches. However, during the last years encouraging results of recently introduced tyrosine kinase inhibitors (TKI) such as vandetanib have been published. In this study we aimed to correlate the results of \(^{18}\)F-fluorodeoxyglucose ([\(^{18}\)F]FDG) positron emission tomography (PET) imaging with treatment outcome.
Methods: Eighteen patients after thyroidectomy with recurrent/advanced MTC lesions receiving vandetanib (300 mg orally/day) could be analysed. A baseline \(^{18}\)F-FDG PET prior to and a follow-up \(^{18}\)F-FDG PET 3 months after TKI initiation were performed. During follow-up, tumor progression was assessed every 3 months including computed tomography according to RECIST. Progression-free survival (PFS) was correlated with the maximum standardized uptake value of \(^{18}\)F-FDG in lymph nodes (SUV(LN)max) or visceral metastases (SUV(MTS)max) as well as with clinical parameters using ROC analysis.
Results: Within median 3.6 years of follow-up, 9 patients showed disease progression at median 8.5 months after TKI initiation. An elevated glucose consumption assessed by baseline \(^{18}\)F-FDG PET (SUV(LN)max > 7.25) could predict a shorter PFS (2 y) with an accuracy of 76.5% (SUV(LN)max <7.25, 4.3 y; p=0.03). Accordingly, preserved tumor metabolism in the follow-up PET (SUV(MTS)max >2.7) also demonstrated an unfavorable prognosis (accuracy, 85.7%). On the other hand, none of the clinical parameters reached significance in response prediction.
Conclusions: In patients with advanced and progressive MTC, tumors with higher metabolic activity at baseline are more aggressive and more prone to progression as reflected by a shorter PFS; they should be monitored more closely. Preserved glucose consumption 3 months after treatment initiation was also related to poorer prognosis.